Dynamic infrared imaging of newly diagnosed malignant lymphoma compared with Gallium-67 and Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography.

@article{Janicek2003DynamicII,
  title={Dynamic infrared imaging of newly diagnosed malignant lymphoma compared with Gallium-67 and Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography.},
  author={Milos J Janicek and GoergeD. Demetri and Miroslav Jan{\'i}cek and Kevin Shaffer and M. A. La Fauci},
  journal={Technology in cancer research & treatment},
  year={2003},
  volume={2 6},
  pages={571-8}
}
Staging and therapy monitoring of malignant lymphomas relies heavily on imaging using arbitrary size criteria from computed tomography (CT) and sometimes non-specific radionuclide studies to assess the activity of the disease. Treatment decisions are based on early assessment of the response to therapy and the residual volume of the disease. Our initial experience is reported using a new noninvasive, inexpensive, and reproducible passive imaging modality, Dynamic Infrared Imaging (DIRI), which… CONTINUE READING